Summary:
This study is being done to evaluate the efficacy of an investigational once-daily oral drug on the incidence of cardiovascular death, myocardial infarction (MI) (heart attack) or ischemic stroke in patients with type 2 diabetes.
Inclusion Criteria:
•Male or female >40 years of age
•Diagnosis of Type 2 diabetes
•High risk for cardiovascular events
Exclusion Criteria:
•Diagnosis of Type 1 diabetes mellitus
•History of bladder cancer or history of radiation therapy to the lower abdomen or pelvis at any time
•Chronic cystitis and/or recurrent urinary tract infections
•Pregnant or breast-feeding
Qualified Participants May Receive:
The study drug as well as all research-related tests, procedures and visits will be provided at no cost to the subject and their insurance.
Additionally, the subject will receive $50 for each scheduled clinic visit completed. The subject will not be charged for parking while attending study visits.